RegisterLogin

BMS-986339

CAT: 0804-HY-150787Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-150787Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BMS-986339 is an orally active, potent FXR agonist. BMS-986339 forms H-bond with His298 and ASN287 residues. BMS-986339 can be used in the research of primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH), anti-fibrosis[1].
CAS Number
[2477873-64-4]
UNSPSC
12352005
Target
Cytochrome P450; FXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/bms-986339.html
Solubility
10 mM in DMSO
Smiles
CC(F)(C1=NC(C23CCC(CC2)(CC3)CN(C4=CC(C5=CC=C(C=C5)C(C)(O)C)=CC=C4)C([C@H]6C[C@@](O)(C6)C(F)(F)F)=O)=NO1)C
Molecular Formula
C35H41F4N3O4
Molecular Weight
643.71
References & Citations
[1]Susheel J Nara, et al. Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis. J Med Chem. 2022 Jul 14;65 (13) :8948-8960.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2

Related Products

CatalogName
HY-139562BMS-986318
HY-119886BMS-986169
HY-162555BMS-986308
HY-P10375-01BMS-986189
HY-139396-01BMS-986299
HY-131180-01BMS-986235
HY-120637BMS-986034
HY-172320-01BMS-986238
HY-173630-01BMS-986449
HY-159646-01BMS-986397

Alternative Products

CatalogName
T73155-01BMS-986339
MBS386661-01BMS-806 (BMS 378806)
A11201-1BMS-806 (BMS 378806) 1mg
A11201-2BMS-806 (BMS 378806) 2mg
A11201-500BMS-806 (BMS 378806) 500mg
A11201-25BMS-806 (BMS 378806) 25mg
MBS3616196-01BMS 193885
MBS3607783-01BMS-833923
MBS3607487-01BMS-378806
MBS3602996-01BMS-986195

Popular Products